Transient and fully reversible leukocytosis in a myelodysplastic syndrome patient upon initiation of azacitidine treatment

被引：0
|
作者：
Georg Feldmann
Peter Brossart
Marie von Lilienfeld-Toal
机构：
[1] University Hospital of Bonn,Department of Internal Medicine 3, Center of Integrated Oncology (CIO) Cologne
[2] Jena University Hospital,Bonn
来源：
Annals of Hematology | 2013年 / 92卷
关键词：
White Blood Cell Count; Lenalidomide; Myelodysplastic Syndrome; Hydroxyurea; Azacitidine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1577 / 1579
页数：2
相关论文
共 50 条
  • [41] Autoimmune hemolytic anemia in a patient with myelodysplastic syndrome: Responding to 5-azacitidine therapy
    Kaur, Jaspreet
    Tuler, Shahaf
    Dasanu, Constantin A.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (07) : 1775 - 1778
  • [42] Azacitidine-Induced Pneumonitis in a Patient with Myelodysplastic Syndrome: First Case Report in Japan
    Hayashi, Makoto
    Takayasu, Hiromi
    Tada, Mami
    Yamazaki, Yohei
    Tateno, Hidetsugu
    Tazawa, Sakiko
    Wakabayashi, Aya
    Iwasaki, Takuya
    Tsuchiya, Yutaka
    Yamashita, Jun
    Takeda, Norikazu
    Tomita, Shogo
    Mori, Hiraku
    Kokubu, Fumio
    INTERNAL MEDICINE, 2012, 51 (17) : 2411 - 2415
  • [43] Disseminated Varicella-Zoster Virus Infection Following Azacitidine in a Patient With Myelodysplastic Syndrome
    Zhou, Guiyun
    Houldin, Arlene D.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2009, 13 (03) : 280 - 284
  • [44] Treatment of perianal infection in a patient with myelodysplastic syndrome
    Zhong, Shijiang
    You, Ting
    Wang, Wei
    Li, You
    ASIAN JOURNAL OF SURGERY, 2024, 47 (08) : 3541 - 3542
  • [45] Transient Charles Bonnet syndrome in a patient with reversible cerebral vasoconstriction syndrome
    Yagi, Yohsuke
    Watanabe, Yukiko
    Yokote, Hiroaki
    Amino, Takeshi
    Kamata, Tomoyuki
    NEUROLOGICAL SCIENCES, 2013, 34 (06) : 1023 - 1025
  • [46] Transient Charles Bonnet syndrome in a patient with reversible cerebral vasoconstriction syndrome
    Yohsuke Yagi
    Yukiko Watanabe
    Hiroaki Yokote
    Takeshi Amino
    Tomoyuki Kamata
    Neurological Sciences, 2013, 34 : 1023 - 1025
  • [47] Successful Treatment of Hemophagocytic Lymphohistiocytosis Associated with Low-risk Myelodysplastic Syndrome by Azacitidine
    Daitoku, Shinya
    Aoyagi, Tomomi
    Takao, Shinichiro
    Tada, Seiya
    Kuroiwa, Mika
    INTERNAL MEDICINE, 2018, 57 (20) : 2995 - 2999
  • [48] Late Hematological Improvement of Myelodysplastic Syndrome Following Treatment with 5-Azacitidine Therapy
    Takaoka, Kensuke
    Hangaishi, Akira
    Ito, Ayumu
    Morioka, Takehiko
    Kida, Michiko
    Usuki, Kensuke
    INTERNAL MEDICINE, 2014, 53 (19) : 2241 - 2243
  • [49] Long-term hematologic response after azacitidine treatment in a lower-risk myelodysplastic syndrome patient: A case report
    Loukidis, Konstantinos
    Tschopp, Marcel
    LEUKEMIA RESEARCH REPORTS, 2024, 21
  • [50] Successful treatment by azacitidine therapy of intestinal Behcet's disease associated with myelodysplastic syndrome
    Tanaka, Hiroaki
    Shimizu, Naomi
    Tougasaki, Emi
    Kawajiri, Chika
    Hashimoto, Shinichiro
    Takeda, Yusuke
    Sakai, Shio
    Takeuchi, Masahiro
    Ohwada, Chikako
    Sakaida, Emiko
    Takagi, Toshiyuki
    Nakaseko, Chiaki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (04) : 520 - 524
12345